Yellow fever has been written off in the past as a global threat. Yet the failure to eradicate this disease has left the door open for new, large, outbreaks as vaccination of travellers and tropical populations declines, according to an article in the February issue of Microbiology Today magazine from the Society for General Microbiology.
"Yellow fever virus attracts less public attention than, for instance, lassa and ebola, but it remains the greater threat. Containment through effective mosquito control and vaccination of those at risk, including travellers, remains an important though frequently neglected goal," explains author Dr Philip Mortimer, of the Central Public Health Laboratory, London.
"Today there are few promises of global eradication, and encroachment on tropical forests in South America and West Africa may actually be increasing the danger when populations are not vaccinated," says Dr Mortimer.
The 17D vaccine for yellow fever, like other types of live attenuated vaccines, carries a remote risk of reversion to the disease-causing form. Not only, therefore, is vaccine protection not being afforded to all the tropical populations who may need it, but its use is now also being questioned among travellers to the Tropics.
"The scientific means exist to keep the global threat of yellow fever under control, but they carry a large financial and possibly a human cost," says Dr Mortimer.
Tracey Duncombe | Source: alphagalileo
Further information: www.sgm.ac.uk
More articles from Health and Medicine:
Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps
24.11.2009 | Johns Hopkins Medical Institutions
Moderate-to-Heavy Exercise May Reduce Risk of Stroke for Men
24.11.2009 | American Academy of Neurology
Daycare may double TV time for young children
24.11.2009 | Studies and Analyses
Insomnia prevalent among cancer patients who receive chemotherapy
24.11.2009 | Studies and Analyses
24.11.2009 | Social Sciences
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News